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Abstract: ETHE1 (ethylmalonic encephalopathy protein 1) is a β-lactamase 
fold-containing protein that is essential for the survival of a range of 
organisms. In spite of the apparent importance of this enzyme, very little is 
known about its function or biochemical properties. In this study Arabidopsis 
ETHE1 was over-expressed and purified and shown to bind tightly to 1.2 ± 
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0.2 equivalents of iron. 1H NMR and EPR studies demonstrate that the 
predominant oxidation state of Fe in ETHE1 is Fe(II), and NMR studies confirm 
that two histidines are bound to Fe(II). EPR studies show that there is no 
antiferromagnetically-coupled Fe(III)Fe(II) center in ETHE1. Gel filtration 
studies reveal that ETHE1 is a dimer in solution, which is consistent with 
previous crystallographic studies. Although very similar in terms of amino acid 
sequence to glyoxalase II, ETHE1 exhibits no thioester hydrolase activity, and 
activity screening assays reveal that ETHE1 exhibits low level esterase 
activity. Taken together, ETHE1 is a novel, mononuclear Fe(II)-containing 
member of the β-lactamase fold superfamily. 
Keywords: β-lactamase fold, Fe(II), ETHE1, NMR spectroscopy, EPR 
spectroscopy 
Introduction 
Mutations in the ethylmalonic encephalopathy protein 1 (ETHE1) 
are responsible for the complex human disease ethylmalonic 
encephalopathy (EE) [1, 2]. The symptoms of EE are well 
characterized, yet the underlying physiological cause of the disease 
remains unknown [1]. Symptoms associated with EE include chronic 
diarrhea, a delay in neural development, symmetric brain lesions, 
relapsing petechiae, lactic academia, and acrocyanosis of the hands 
and feet, all of which lead to death within the first few years of life [3]. 
Biochemical alterations associated with of EE include elevated levels of 
C4 and C5 plasma acylcarnitines and elevated levels of ethylmalonic 
acid (EMA). Based on these biochemical alterations, it has been 
suggested that ETHE1 may be involved in the β-oxidation of short-
chain acyl-CoAs [1]. 
ETHE1-like enzymes are found in most organisms including 
archaebacteria, insects, plants, and animals, suggesting that ETHE1 
serves a fundamental biochemical role in nature; however, the exact 
biochemical role of ETHE1 is currently unknown. ETHE1 is most similar 
to the glyoxalase II family of proteins that catalyze the second step of 
the glyoxalase pathway. The glyoxalase pathway, which consists of 
glyoxalase I (lactoylglutathione lyase) (GLX1) and glyoxalase II 
(hydroxacylglutathione hydrolase) (GLX2), is thought to be involved in 
the detoxification of 2-oxoaldehydes, toxic by-products of 
carbohydrate and lipid metabolism [4]. The primary physiological 
substrate appears to be methylglyoxal (2-oxopropanal), a reactive α-
oxoaldehyde [4]. 
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GLX2 enzymes belong to the metallo-β-lactamase fold family of 
proteins, which are typically dinuclear metallohydrolases. The metallo-
β-lactamases typically bind two equivalents of Zn(II) and hydrolyze β-
lactams [5, 6]. GLX2 enzymes, which hydrolyze SLG, contain dinuclear 
metal centers that can bind Zn, Fe, and Mn [7]. Additional protein 
families containing the β-lactamase fold include the rubredoxin:oxygen 
oxidoreductase (ROO) and ZiPD families, which have been shown to 
bind divalent Fe and Zn(II), respectively [8, 9]. Therefore, the β-
lactamase fold can accommodate several different metals and is 
present in enzymes that can catalyze a wide range of reactions. 
Arabidopsis ETHE1 is 54% identical to human ETHE1. Crystal 
structure comparisons between Arabidopsis ETHE1 [10] and 
Arabidopsis GLX2-5, a mitochondrial GLX2 enzyme [11], revealed that 
while the proteins show only 13% sequence identity, ETHE1 is 
structurally very similar to GLX2 [12]. ETHE1 and GLX2 enzymes 
contain a very similar metal binding domain and the β-lactamase fold 
consisting of two central mixed β-sheets surrounded on both sides by 
helices [12, 13]. Interestingly, even though ETHE1 and GLX2 enzymes 
exhibit extensive similarity in their metal binding regions, the ETHE1 
crystal structure showed it only bound a single metal atom [12]. In 
fact, the crystal structure was best refined to a metal occupancy of 0.5 
[12]. However, the metal content of purified ETHE1 was reported to be 
2 equivalents of metal per equivalent of protein, raising the question of 
the actual metal content of this enzyme. 
We have over-expressed, purified, and biochemically- and 
spectroscopically-characterized Arabidopsis ETHE1 to further 
investigate structural and biochemical properties of ETHE1 enzymes 
and to better understand the functional role of ETHE1. The results of 
these studies show that Arabidopsis ETHE1 is homodimeric in solution, 
exhibits low-level esterase activity, and specifically binds a single 
Fe(II) atom in the active site. 
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Materials and Methods 
Over-expression and purification of A.t. ETHE1 
The Arabidopsis ETHE1 cDNA was obtained from Arabidopsis 
bud RNA and cloned into pET24b as Nde1 and XhoI fragments 
following reverse transcription and PCR amplification using the primers 
GLX2-3 (TCTTCTCATATGAAGCTTCTCTTTCGTCAAC) and a 3′poly (A) 
anchor primer. During cloning the N-terminal leader peptide was 
removed for high-level expression of ETHE1 in E. coli, resulting in the 
amino terminal methionine, which corresponds to amino acid 50 of the 
predicted protein sequence. This is the same form of the protein that 
was used for crystal structure determination [12]. After verification by 
DNA sequencing, pET24b-ETHE1 was transformed into BL21-Codon 
Plus (DE3)-RIL cells and used for protein over-expression and 
purification as previously described [7]. Protein purity was determined 
by SDS-polyacrylamide gel electrophoresis, and protein concentrations 
were determined by using an extinction coefficient (ε280nm) of 7,240 
M−1cm−1, which was determined using amino acid analyses. 
Metal analyses 
Metal analyses were performed on the purified enzyme using a 
Varian-Liberty 150 inductively coupled plasma spectrometer with 
atomic emission spectroscopy detection (ICP-AES) as described 
previously [13]. The purified protein was diluted to 10 μM in 50 mM 
TRIS, pH 7.2, and analyzed for the presence of zinc, manganese, iron, 
and copper. The data presented in this report represent the average of 
at least three preparations for each metal addition experiment. 
Native molecular weight determination 
The native molecular weight of ETHE1 was determined by 
utilizing a Sephacryl S200 column in 10 mM MOPS, pH 7.2, containing 
0.15 M NaCl. ETHE1 (1 mg), purified as described above, was mixed 
with 1 mg of each of the protein standards: Blue Dextran, bovine 
serum albumin, ovalbumin, aldolase, and ribonuclease A. One milliliter 
fractions were collected with a flow rate of 0.5 ml/min, and samples 
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containing protein were identified by monitoring A280 and by SDS-PAGE 
gel analysis. 
Substrate analysis 
Enzymatic assays were conducted at 25 ºC in 10 mM MOPS, pH 
7.2, on a Cary IE UV-Vis spectrophotometer. A series of thioesters of 
glutathione were synthesized as previously described [14], and all 
other substrates were purchased commercially. The hydrolysis of S-D-
lactoylglutathione (Sigma), S-D-acetylglutathione, S-D-
acetoacetylglutathione, S-D-formylglutathione, S-D-
glyocosylgutathione or S-D-pyruvylglutathione was monitored at 240 
nm. S-D-mandeloylglutathione hydrolysis was monitored at 263 nm 
[14]. Hydrolysis of p-nitrophenyl phosphate (Sigma), p-nitrophenyl 
sulfate (Sigma), and p-nitrophenyl acetate (Sigma) was monitored at 
400 nm [15–17]. The hydrolysis of L-alanine-p-nitroanilide (Sigma) 
was measured at 404 nm [16]. Ala-ala-ala-p-nitroanilide (Sigma) and 
y-L-Glu-p-nitroanalide (Sigma) hydrolysis was monitored at 410 nm. 
Hydrolysis of benzoylglycyl-L-phenylalanine was monitored at 254 nm 
[18]. Nitrocefin (Becton-Dickinson) hydrolysis was monitored at 485 
nm [19]. Methylglyoxal was assayed colorimetrically by using the 2,3-
dinitrophenylhydrazine-alkali reaction [20]. Assays were performed for 
5 min using 80 μM substrate and varying concentrations of pure 
enzyme both as-isolated and after loading with excess iron. 
Additional substrate screening was performed using the 
Micronaut-Taxa Profile E (Merlin GmbH) microtiter plate [8]. Each well 
was filled with 25 μl of 40 μM ETHE1, and reactions prepared according 
to manufacturer’s directions. A negative control was performed using 
MOPS, pH 7.2, to rule out non-specific reactions. The reactions were 
monitored visually for 24 hours at 37 ºC, and positive reactions were 
recorded. Each reaction was performed in duplicate using enzyme 
loaded with iron. 
EPR Spectroscopy 
EPR spectra were obtained at 9.63 GHz and 10 K using a Bruker 
EleXsys E580 spectrometer equipped with an ER4116DM cavity, and 
an Oxford ESR900 liquid helium flow cryostat and ITC503 temperature 
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controller. Acquisition parameters included 12 G (1.2 mT) field 
modulation at 100 kHz. Samples contained 1.6 mM ETHE1 protein in 
50 mM TRIS, pH 7.2. 
1H NMR Spectroscopy 
NMR spectra were collected on a Bruker Avance 500 
spectrometer operating at 500.13 MHz, 298 K, and a magnetic field of 
11.7 tesla, recycle delay (AQ), 41 ms, and sweep width, 400 ppm. 
Concentrated samples of ETHE1 (1.4 mM) contained 10% D2O for 
locking or 90% D2O for monitoring of solvent-exchangeable peaks. 
Protein chemical shifts were calibrated by assigning the H2O signal a 
value of 4.70 ppm, and a modified presaturation pulse sequence 
(zgpr) was used to suppress the proton signals that originated from 
the water molecules. 
Results 
Over-expression, purification, and characterization of 
Arabidopsis ETHE1 
Based on publicly-available localization prediction programs (pSORT II, 
Mitoprot), recombinant ETHE1 was cloned into the pET24b expression 
vector after removing the predicted 50 amino acid N-terminal leader 
sequence, which generated an N-terminus of MKLLFRQ (Figure 1). This 
plasmid was transformed into E. coli BL21(RIL) Rosetta cells, and 
ETHE1 was over-expressed as described in Material and Methods. 
ETHE1 was purified using FPLC Q-Sepharose chromatography, eluting 
from the column at ~125 mM NaCl. Purified ETHE1 protein was 
obtained in high yield (~40–60 mg of protein/L) and was >95% pure 
(data not shown). 
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Figure 1: Sequence Alignment of ETHE1 and select metallo-β-lactamase fold 
proteins 
Protein sequences were aligned using CLUSTAL W (1.83). Identical residues are 
highlighted with black and similar residues with gray highlight. Conserved metal 
binding ligands are indicated by closed triangles. Residues labeled with an asterisk are 
mutated in patients with EE. Predicted N-terminal processing site is indicated by an 
arrow. 
ETHE1 is a dimer in solution 
In contrast to the GLX2 enzymes, which exist as monomers in 
solution [21, 22], the crystal structure of Arabidopsis ETHE1 suggested 
that it has a dimeric quaternary structure [12]. Gel filtration studies 
were performed on the recombinant ETHE1 enzyme to test this 
hypothesis. ETHE1 eluted from a Sephacryl S200 column between 
standard proteins adolase (158 kDa) and ovalbumin (44 kDa), 
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resulting in a calculated molecular weight of 58.3 kDa, which is 
roughly twice the recombinant monomeric weight of 26.8 kDa (Figure 
2). Therefore, Arabidopsis ETHE1 exists as a dimer in solution. 
 
Figure 2: Gel filtration elution profile of internal protein standards and ETHE1 
Approximately 1 mg of each of the following internal protein standards was separated 
on a Sephacryl S200 column: blue dextran, bovine serum albumin, ovalbumin, 
aldolase, and ribonuclease A. Protein containing fractions were monitored by A280 as 
well as by SDS-PAGE. 
Metal Analyses 
GLX2 enzymes have been shown to bind iron, zinc, and 
manganese; therefore, ETHE1 was analyzed for all three of these 
metals and also copper [11, 23]. The preparation of ETHE1 in rich 
medium containing no added metal ions resulted in an isolated enzyme 
that bound 0.2 equivalents of iron and no other metal ions at levels 
detectable with ICP-AES. When grown and over-expressed in rich 
medium containing 250 μM Fe(NH4)2(SO4)2 and Zn(SO4)2 or 250 μM 
MnCl2, ETHE1 was found to contain 0.33 ± 0.10 equivalents of iron 
and less than 0.003 equivalents of zinc, manganese, and copper. While 
low, this result suggested that ETHE1 may preferentially bind iron. The 
purified enzyme was incubated with a 4-molar excess of Fe(II) and 
dialyzed extensively (4X1L for four hours each) to remove loosely- or 
unbound Fe, and ETHE1 was found to bind 1.2 ± 0.2 equivalents of 
iron, and no detectable traces of zinc, manganese, or copper. This 
result is consistent with the crystal structure [12], which showed that 
when prepared this way, ETHE1 only binds 1 equivalent of iron. Unlike 
the GLX2 enzymes, the addition of excess zinc or manganese to the 
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isolated enzyme resulted in no additional metal binding, suggesting 
that ETHE1 may be specific for iron. 
ETHE1 Does Not Hydrolyze SLG 
ETHE1 had previously been predicted to be a GLX2-like enzyme [10]. 
However, ETHE1 is lacking several highly-conserved amino acids 
known to participate in the hydrogen bonding of SLG in GLX2 [12, 13]. 
Furthermore, crystallographic analysis showed that the substrate 
binding pocket of ETHE1 is too small to accommodate SLG [12]. These 
results suggested that Arabidopsis ETHE1 does not utilize SLG as a 
substrate. ETHE1, both as-isolated and after incubation with excess 
iron, was assayed for thioesterase activity with SLG and various other 
thioester derivatives of glutathione to test this hypothesis. Consistent 
our prediction, purified ETHE1 did not hydrolyze any of the glutathione 
thioesters. 
As-isolated ETHE1 and Fe-enriched ETHE1 were also assayed 
against 188 different substrates, including 95 substrates for 
peptidases, 17 substrates for diverse reactions, and 76 substrates for 
glycolytic enzymes, phosphatases, and esterases using a 
commercially-available substrate screening plate [8] to investigate 
potential substrates. Three potential substrates were identified through 
this screening process: Ala-Ala-Ala-p-nitroanilide (NA), Glu-pNA, and 
p-nitrophenyl acetate (NPA). Upon further characterization, Ala-Ala-
Ala-pNA and Glu-pNA were found not to be substrates for ETHE1. 
However, ETHE1 did exhibit a low level of activity against p-NPA (2.02 
± 0.46 nmols/min/mg of enzyme). This low level of activity is similar 
to the esterase activity (25.8 nmols/min/mg) observed in recombinant 
rat carbonic anhydrase III when reacted with p-nitrophenyl acetate 
[24]. The activity of ETHE1 towards p-nitrophenyl acetate was 
inhibited by the presence of a metal chelator, 1,10-o-phenanthroline, 
indicating that p-nitrophenyl acetate hydrolysis by ETHE1 requires 
bound metal. Therefore, based on these results and those of the 
crystal structure, we predict that the ETHE1 substrate may be a 
relatively small ester. 
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Spectroscopic Studies on ETHE1 
The metal binding site of iron-bound ETHE1 was investigated 
using 1H NMR spectroscopy (Figure 3). The spectrum revealed the 
presence of 3 paramagnetically-shifted, down field resonances 
between 200 and 20 ppm and no observable up field resonances > 
−30 ppm. In this spectrum peaks a and c integrate to 1 proton each, 
while peak b integrates to 2–3 protons (Figure 3). Spectra were 
obtained at 7 °C and 35 °C, and while all three peaks shifted up field 
with increasing temperature, peak b did not split into 2 or more peaks, 
suggesting that this peak is due to at least 2 chemically-equivalent 
protons. To further investigate the identity of these protons, an NMR 
spectrum of ETHE1 in 80–90% D2O was obtained (Figure 3). Peaks a 
and c broadened slightly but still integrate to 1 proton each. The 
intensity of peak b decreased by 85%. Based on the resonance 
positions and line widths, peak b can be assigned to two N-H protons 
on histidines bound to Fe(II) or possibly to an antiferromagnetically-
coupled Fe(III)Fe(II) center [25, 26]. The ETHE1 crystal structure 
shows that both of the histidine ligands are bound through the ε 
nitrogen, and therefore, peaks a and c are likely due to the β-CH2 
protons on the bound Asp ligand (Figure 3). We cannot rule out the 
possibility that these peaks are due to ortho protons on metal bound 
histidines, but these peaks are usually too broad to detect [27]. The 
NMR data were surprising, since we initially predicted that ETHE1 
would have a metal binding site similar to those in the GLX2 family. 
NMR spectra from GLX2-5, which can contain a dinuclear iron center, 
shows at least eight paramagnetically-shifted resonances in between 
110 and −30 ppm that correspond to protons on ligands bound to a 
Fe(III)Fe(II) antiferromagnetically-coupled center [11]. The recent 
crystal structure of ETHE1 demonstrated that His74 (His56 in GLX2-5) 
may not be in a position to coordinate a bound metal ion [12], which is 
consistent with NMR spectrum of ETHE1. 
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Figure 3: 1H NMR spectra of 1.4 mM iron-bound ETHE1 at pH 7.2 in water and 
80–90% D2O 
The spectra were obtained on a Bruker Avance 500 spectrometer operating at 500.13 
MHz, 298 K, and a magnetic field of 11.7 tesla, recycle delay (AQ), 41 ms; sweep 
width, 400 ppm. 
EPR spectra on several different forms of ETHE1 were obtained 
to further investigate the ETHE1 metal center. The spectrum of as-
isolated ETHE1 containing 0.33 equivalents of Fe (‘Feiso-ETHE1’) 
indicated the presence of rhombic Fe(III) (Figure 4). The signal was 
dominated by a broad derivative feature at geff = 4.27; no features 
that could be considered diagnostic for protein-bound Fe(III) were 
observed and the origin of the signal is, therefore, unclear. Although 
precise quantitation of high-spin systems for which more than one 
Kramers’ doublet is populated is not trivial, double integration and 
comparison with a similar EPR signal due to Fe(III) from a well-
characterized (4-hydroxyphenyl) pyruvate dioxygenase [21] indicated 
an Fe(III) content of about 0.025 mM. Therefore about 95 % of the 
iron in Feiso-ETHE1 is EPR-silent. 
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Figure 4: EPR spectram of 1.6 mM ETHE1 under different conditions 
A, ETHE1 as-isolated containing 0.33 equivalents of Fe; B, iron-enriched 
ETHE1 containing 1.2 equivalents of Fe; C, iron-enriched ETHE1 after 2 cycles 
of freeze/thaw; D, iron-enriched ETHE1 after 4 days at 4º C. Spectra were 
collected on a Bruker ESP-300E spectrometer containing an ESR-900 helium 
flow cryostat operating at 4.7 K with 2 milliwatts of microwave power at 9.48 
GHz and 10 G-field modulation at 100 kHz. 
An Fe(III) signal with a resonance at g ~ 4.3 and additional 
absorption features at lower field were observed from the analysis of 
ETHE1 enzyme containing 1 equivalent of Fe (Fe1-ETHE1) (Figure 4B). 
In this spectrum, the resonance positions indicated a dominant zero-
field splitting term (i.e., D,E ≫ gβBS; the lower field resonances 
centered at g ~ 5.5 and g ~ 9 terminate abruptly at g = 6 and g = 10, 
respectively); the lack of resolved structure and the broad absorption 
from g ~ 4.3 to g ~ 10 indicate a fairly broad distribution of the 
rhombic zero-field splitting parameter (i.e., strains in E/D) and thermal 
population of at least two Kramers’ doublets [22]. Again, the signal 
was not definitive for site-specific binding of Fe(III) by ETHE1, 
although the form of the signal, particularly the inflection on the g ~ 
4.3 crossover due to incomplete rhombicity (i.e., E/D is slightly less 
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than 1/3), is highly reminiscent of the spectrum due to Fe(III) bound to 
the active site of the metallo-β-lactamase GOB [26]. The intensity of 
the signal was somewhat lower than that of the as-isolated ETHE1 and 
accounted for < 1 % of the total iron. Interestingly, there was no 
evidence for a ‘g ~ 1.7, 1.8, 1.9’ signal due to an Fe(II)-Fe(III) center 
[28]. 
We attempted to disrupt the protein structure of Fe1-ETHE1 by 
applying freeze-thaw cycles, but the EPR signal remained relatively 
constant (Figure 4C; fewer scans were averaged). Efforts to produce 
more Fe(III) in the sample by addition of hydrogen peroxide resulted 
in rapid protein precipitation. The intensity of the Fe(III) signal was 
found to increase by a factor of 4 upon aerobic incubation for 100 h at 
4 °C (Figure 4D). The form of this spectrum is clearly distinct from 
that of Feiso-ETHE1, but still accounts for < 5 % of the total Fe. 
Because of a weak background signal due to trace Mn(II) and Cu(II), 
the possibility of the presence of a signal due to an Fe(II)-Fe(III) 
center cannot be ruled out completely, but the population of such a 
center, if not zero, must be very low. 
Discussion 
Results presented in this work represent the first detailed 
characterization of an ETHE1 protein from any organism. ETHE1 is 
most similar to the GLX2-family of proteins, which are members of the 
metallo-β-lactamase superfamily. This superfamily consists of proteins 
that catalyze a wide range of reactions but share the common metal 
binding motif H-x-[EH]-x-D-[CRSH]-X50-70-[CSD]-X, which is part of 
the common β-lactamase fold [29]. This motif typically consists of two 
metal ions that are essential for the activity of the majority of the 
enzymes [29]. In most β-lactamase fold containing proteins, the 
coordination of the first metal (Zn1 site) is tetrahedral and consists of 
three histidines and a bridging hydroxide, while the second metal 
binding site (Zn2 site) is trigonal pyramidal. The site 2 metal binding 
ligands are more variable but always contain a histidine and aspartic 
acid (Figure 5A) [29]. Because of the similarity of ETHE1 to the GLX2 
family of enzymes, it was predicted that ETHE1 would also bind two 
equivalents of metal. Metal analyses of ETHE1 done prior to this paper 
were based on a calculated extinction coefficient of 10,240 M−1cm−1 
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[12]. Metal analyses using this extinction coefficient indicated that 
iron-bound ETHE1 contained two equivalents of iron; however, the 
ETHE1 crystal structure reported only a 0.5 iron metal occupancy [12]. 
It was originally thought that this discrepancy resulted from the loss of 
metal during the crystallization processes [12]. However, results 
presented here suggest that the extinction coefficient used for these 
experiments is inaccurate. When using amino acid analyses, an 
extinction coefficient of 7,240 M−1cm−1 was obtained, which leads to a 
metal:protein stoichiometry of 1.2 ± 0.2. This number is consistent 
with the ETHE1 crystal structure [12]. 
 
Figure 5: Metal binding sites of (A) A. thaliana GLX2-5 and (B) A. thaliana ETHE1. In 
GLX2-5, Zn(II) is coordinated by His54, His56, His112, Asp131, and a bridging 
hydroxide, and Fe(III) is coordinated by Asp58, His59, His169, Asp131, and the 
bridging hydroxide. In ETHE1, Fe(II) is coordinated by His72, His128, Asp153, and 
three solvent molecules. 
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The crystal used to solve the structure of ETHE1 took several 
months to grow, and we were concerned that the resulting structure 
was due to an analog of the protein that was not biologically-relevant. 
However, consistent with the crystal structure of ETHE1, our 
spectroscopic results suggest that ETHE1 contains a single Fe(II) that 
is coordinated by two histidines (Figure 3) [12]. GLX2 enzymes 
enriched in iron typically contain an antiferromagnically-coupled 
Fe(II)-Fe(III) center in their dinuclear metal binding site [11, 23, 30], 
due to the positive cooperative metal binding of these proteins. 
Results from our EPR studies argue against the presence of an Fe(II)-
Fe(III) site in ETHE1. Two distinct EPR signals were observed for 
ETHE1, both due to magnetically-isolated Fe(III) and both accounting 
for only a very small proportion (1 – 5 %) of the total iron. Even 
extensive exposure to air was unsuccessful in increasing the Fe(III) 
signal. The very low intensities of the Fe(III) signals can either be due 
to most of the iron being in the Fe(II) state or most of the iron 
residing in an anti-ferromagnetically-coupled S′ = 0 dinuclear site. The 
lack of signals due to an Fe(III)-Fe(II) center and the crystallographic 
identification of a monometallated active site [12] both argue against a 
predominant Fe(III)-Fe(III) S′ = 0 species and support Fe(II) as the 
predominant oxidation state of the metal in ETHE1. 
Even though ETHE1 contains all of the highly-conserved metal 
binding ligands of the metallo-β-lactamase family of proteins [19], 
ETHE1 does not bind two equivalents of metal. In agreement with this 
result, the crystal structure identified changes in the tertiary structure 
of the metal binding domain that do not allow for the coordination of a 
second metal atom (Figure 5B) [12]. Based on the amino acid 
sequence comparison, we anticipated that the Zn1 site in ETHE1 would 
be made up of His72, His74, His128, and Asp153, while the Zn2 site 
would have Asp76, His77, Asp153, and His194. In ETHE1, Fe binds to 
3 of the 4 ligands in the Zn1 site (His72, His128, and Asp153). A 
single-turn helix in ETHE1 containing His74 is pulled away from the 
active site, displacing His74 4.4 Å away from the metal atom in ETHE1 
relative to GLX2-5. This unwinding of the helix also displaces the side 
chains of Asp76 and His77, and the comparable amino acids in GLX2-5 
(Asp58 and His59) bind metal in the Zn2 site (Figure 5) [12]. 
Therefore, subtle changes in protein conformation have displaced 
several of the metal binding ligands, ultimately limiting the ability of 
ETHE1 to bind two metal ions. 
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There are other examples of metallo-β-lactamases that only 
bind one metal. CphA from Aeromonas hydrophila and GOB-1 from 
Elizabethkinga meningosptica both only bind a single Zn(II) atom in 
the Zn2 site (Asp, Cys, His) [31, 32]. However, in these enzymes, the 
Zn1 site is altered either by the replacement of a histidine with an 
asparagine in CphA or a histidine with glutamine in GOB-1 [31–33]. To 
our knowledge ETHE1 is the first example of a β-lactamase family 
protein that contains all of the conserved metal-binding ligands, yet 
only binds one metal ion. 
In addition, it has been shown that the presence of soft or hard 
ligands in the metal binding site can affect the specificity of the metal 
binding [29]. All of the metallo-β-lactamases exclusively bind Zn(II) 
[29]. The incorporation of an aspartic acid and an additional histidine 
in the Zn2 site likely allows for the variable binding of Fe, Zn, and Mn 
seen in the GLX2 enzymes (Figure 5A) [7, 11, 13, 30]. Likewise, the 
replacement of two soft ligands by an aspartic acid and a glutamate as 
observed in ROO allows the formation of a di-iron center [9, 29]. 
Interestingly, in the ETHE1 crystal structure, the Fe ion is bound in the 
Zn1 site that has been modified by the removal of a histidine and the 
shifting the GLX2 bridging aspartic acid to specifically coordinate the 
iron (Figure 5B) [12]. The Fe(II) ion is further coordinated by three 
water molecules resulting in an octahedrally-bound metal [12, 34], 
unlike the tetrahedral coordination of metal normally seen in the Zn1 
site of metallo-β-lactamases. 
Therefore, ETHE1 proteins appear to represent a new class in 
the metallo-β-lactamase fold family of proteins. Although structurally 
very similar to the GLX2 enzymes, ETHE1 appears to have evolved to 
bind a single iron atom in an octahedral configuration. Metal analyses 
and spectroscopic data suggest that unlike GLX2 enzymes ETHE1 
tightly binds to a single Fe(II) atom in a modified Zn1 site of the 
metallo-β-lactamase metal binding motif. Finally we show that ETHE1 
is homodimeric in solution and exhibits low levels of esterase activity, 
suggesting that ETHE1 might hydrolyze a short-chain ester. The metal 
binding site in ETHE1, with 2 His, 1 Asp, and 3 water molecules (Figure 
5B), resemble the 2-His-1-carboxylate facial triad, which has been 
reported in a number of O2-utilizing reactions [35, 36]. However, 
ETHE1 does not share similar tertiary structural or amino acid 
sequence motifs with any of the enzymes known to have the 2-His-1-
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carboxylate facial triad. In addition, a 1H NMR spectrum on a sample of 
ETHE1 containing α-ketoglutarate showed no change in the resonance 
positions of the paramagnetically-shifted protons, suggesting that 
ETHE1 is not an α-ketoglutarate-dependent enzyme (data not shown). 
Further experiments are required to further classify the ETHE1 
substrate and ultimately understand its biochemical role. 
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